Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities    
Net loss $ (252,768) $ (571,972)
Adjustments to reconcile net loss to net cash (used in) provided by operations    
Amortization of debt discount 8,505 11,933
Amortization of expense on note receivable (3,309)
Accreted interest on note receivable  
Net loss from equity method investment 43,812
Unrealized (gain) loss on available - for - sale securities (29,894) 304,524
Bad debt on note receivable 141,000
Gain on disposal of non-controlling investment (83,064)
Decrease (Increase) in    
Accounts receivable – related party 45,000
Interest receivable   (9,026)
Increase in    
Accounts payable and accrued expenses 139,464 147,058
Accounts payable and accrued expenses - related party 60,000
Accumulated losses on unconsolidated investees in excess of investment 1,226
Net cash (used in) provided by operating activities (89,693) 42,182
Net (decrease) increase in cash and cash equivalents (89,693) 42,182
Cash and cash equivalents - beginning of period 235,311 227,558
Cash and cash equivalents - end of period 145,618 269,740
Supplemental disclosure of cash flow information    
Cash paid for interest 27,218
Cash paid for income tax